Hepatologist vs Gastroenterologist: Which Should You See for Liver Disease?

For most digestive complaints — acidity, reflux, bloating, gallstones — start with a gastroenterologist; they manage common liver conditions well. Bring in a hepatologist once the liver itself is the problem: unexplained raised enzymes, fibrosis on FibroScan, chronic hepatitis B or C, suspected cirrhosis, ascites or jaundice. Do not wait for symptoms — in one biopsy series, 18 of 51 fatty-liver patients with normal ALT already had bridging fibrosis or cirrhosis.
— Dr Chetan Kalal, DM Hepatology, Gleneagles Hospital Mumbai

The problem is rarely the wrong doctor — it’s the wrong timing

Patients ask me constantly: gastroenterologist or hepatologist? The honest answer surprises most of them — for most digestive complaints, start with a gastroenterologist. They are trained in the full digestive tract and manage many common liver conditions perfectly well.

The real challenge is not choosing between two competing specialists. It is recognising when liver disease has moved beyond routine management and needs dedicated hepatology expertise — and that moment is far harder to catch than people assume, because liver disease itself is deceptive. Patients feel fine, liver tests fluctuate, there is no pain, so everyone assumes there is time. Advanced liver disease often progresses silently.

This post is a guide to that moment: how the two specialists are trained in India, the pattern of delay I see most often, my rule of thumb for when to bring a hepatologist in, and what the various “liver transplant specialist” titles actually mean. If you have already decided and want to prepare for the visit, my post on questions to ask a liver specialist covers the consultation itself.

How the two specialists are trained in India

The pathways begin identically: MBBS, a three-year MD in General Medicine (or the DNB equivalent), then the NEET-SS examination for a super-speciality seat. They split there.

A gastroenterologist completes a three-year DM in Medical Gastroenterology or its NBEMS counterpart, the DrNB in Medical Gastroenterology — the two are treated as equivalent. The curriculum covers the whole digestive tract, liver included, with heavy procedural training in upper GI endoscopy, colonoscopy, ERCP and endoscopic ultrasound. Liver disease is a substantial part of that training, not an afterthought.

A hepatologist completes a three-year DM in Hepatology. The National Medical Commission’s curriculum puts the rationale plainly: liver disorders are “a major cause of morbidity and mortality among Indians,” and “Hepatology assumes importance as a dedicated specialty to generate skilled manpower.” Training is deep rather than broad — acute liver failure, cirrhosis and portal hypertension, viral and autoimmune hepatitis, metabolic, vascular and drug-induced liver disease, intensive care of the liver patient, pre- and post-transplant management. Under the 2025 NEET-SS bulletin, DM Hepatology accepts MD/DNB General Medicine or Paediatrics as feeder degrees; Medical Gastroenterology accepts General Medicine alone.

Hepatology is the smaller speciality, taught at a limited number of institutions, so most cities have many gastroenterologists and few hepatologists, and the hepatologists cluster around transplant centres. NBEMS, which runs DrNB programmes in 27 super-specialities, offers Medical Gastroenterology but not Hepatology — a “DrNB Hepatology” does not exist. A doctor calling themselves a hepatologist in India will usually hold either a DM in Hepatology, or a DM/DrNB in Gastroenterology followed by dedicated liver or transplant training. Both are legitimate routes, and it is reasonable to ask which one your doctor took.

A pattern I see too often

A recurring story in my practice: patients diagnosed with fatty liver years earlier. Advised to lose weight, improve diet, come back for periodic follow-up — entirely appropriate advice at the time.

Then, gradually: platelet counts decline. Liver stiffness increases. Ultrasound starts showing features of portal hypertension. Abdominal swelling or jaundice appears. Because each change is subtle, not dramatic, most patients keep thinking of it as “just fatty liver.”

By the time they reach a dedicated hepatology clinic, they have already developed compensated — sometimes decompensated — cirrhosis. The conversation shifts from preventing liver disease to managing its complications.

The lesson is not that the original management was wrong. It is that liver disease is dynamic. A diagnosis from five years ago should not set today’s treatment plan in stone.

My rule of thumb

For uncomplicated digestive symptoms — acidity, reflux, constipation, diarrhoea, bloating, gallstones — a gastroenterologist is the right first call.

Bring in a hepatologist early if any of these are present:

• Persistently elevated liver enzymes without a clear explanation
• Liver fibrosis on FibroScan or imaging
• Chronic hepatitis B or C
• Autoimmune or genetic liver disease
• Recurrent jaundice
• Ascites, leg swelling, or hepatic encephalopathy
• Portal hypertension or oesophageal varices
• Suspected cirrhosis
• A liver mass or suspected hepatocellular carcinoma
• Recurrent episodes of unexplained liver injury
• Any discussion of liver transplantation or a second opinion on advanced liver disease

In these situations, specialist hepatology input shapes long-term monitoring, surveillance, treatment decisions, and — when it matters — timely transplant evaluation. The fatty-liver entry on this list now has guideline backing: the 2023 AASLD practice guidance asks primary-care and diabetes clinics to run a blood fibrosis score (FIB-4) and, if that is not reassuring, a liver stiffness test; patients still at intermediate or high risk “should be referred to specialty care for further evaluation and potential intervention.”

If you are unsure whether your reports fit any of these, ask the physician who ordered them. A referral question costs nothing, and the answer is often reassuring.

Are patients being referred too late?

I do not think this is primarily a wrong-specialist problem. It is a late-recognition problem — by patients, families, and sometimes the system itself.

Most people assume liver disease causes obvious symptoms. It does not, not until late. The liver has extraordinary reserve — significant fibrosis, even early cirrhosis, can develop with almost no warning signs.

A second misconception: normal or near-normal liver enzymes mean a healthy liver. They do not. Patients can carry advanced fibrosis or cirrhosis with only modestly abnormal, or entirely normal, blood work. In a biopsy series from Virginia, 51 patients with fatty liver and a normal ALT were compared with 50 whose ALT was raised. The histology was indistinguishable between the groups; 12 of the 51 with normal ALT had bridging fibrosis and 6 had cirrhosis, and diabetes was the only independent predictor of advanced scarring. That is why risk assessment has to go beyond enzymes alone — clinical history, metabolic risk factors, imaging, fibrosis assessment, and follow-up over time all build the real picture.

The evidence on specialist involvement points the same way, and it is honest about what it cannot show. In a New York hospital, 197 patients admitted with decompensated cirrhosis were followed: the 107 who had a gastroenterology consultation alongside their general physician stayed 5.6 days against 10.1, were readmitted within 30 days half as often (13.3% versus 27.8%) and had lower 30-day mortality (7.5% versus 16.7%). Among 28,861 American veterans with liver disease, the 37% who completed an outpatient visit with a gastroenterologist or hepatologist had a 19% lower risk of death at five years after propensity adjustment. Neither study separates hepatologists from gastroenterologists, and I know of no good study that does. Specialist involvement — of either kind — changes outcomes in serious liver disease. Delay is the enemy, not the title.

What is a liver transplant specialist called?

There is not one title — liver transplant care involves several specialists, and the titles get conflated often enough that it is worth untangling properly.

Transplant hepatologist — a hepatologist (liver specialist physician) with additional focused training in the medical management of transplant candidates and recipients: pre-transplant evaluation, donor and recipient work-up, and lifelong post-transplant care. This is usually the specialist coordinating the overall transplant journey.

Hepatologist — a physician subspecialised in liver disease broadly (cirrhosis, hepatitis, fatty liver disease, liver cancer), not necessarily transplant-focused, though many hepatologists do have transplant training.

Transplant surgeon (hepatobiliary or liver transplant surgeon) — performs the surgical procedure itself, for both donor and recipient in a living donor transplant.

Gastroenterologist — manages the broader digestive tract; some also treat common liver conditions, but transplant-specific care sits with hepatology and transplant surgery.

In practice, transplant care is delivered by a multidisciplinary team — the transplant hepatologist typically manages the medical decision-making and long-term follow-up, while the transplant surgeon performs the operation. What that medical role involves, step by step, is set out on my liver transplant specialist page.

Why the confusion happens: patients often assume “liver doctor” is one job. It is not. A patient might see a gastroenterologist for years for fatty liver, then be referred to a hepatologist once the disease progresses, and only meet the transplant surgical team once a transplant is actually being planned — three different specialists, three different points in the same disease course.

On credentials: at a minimum, an MD followed by a DM in Hepatology or Gastroenterology from a recognised institution, generally followed by focused transplant hepatology training at a high-volume liver transplant centre. My own path was MBBS, then MD in General Medicine at Seth GS Medical College and KEM Hospital, Mumbai, then DM in Hepatology at the Institute of Liver and Biliary Sciences (ILBS), New Delhi, completed in 2016 — followed by transplant-focused clinical work at high-volume centres. That is the credential path behind the titles above.

The title matters less than the team behind it. What determines outcomes is coordinated care between hepatology and transplant surgery — not which single name is on the door.

Final thought

I do not want every fatty liver patient sitting in a hepatology waiting room. I do want every patient with progressive, unexplained, or advanced liver disease to get specialist evaluation before complications become irreversible.

In liver disease, the best outcomes rarely come from acting the fastest. They come from recognising the right moment to bring in the right expertise.

References

1. National Medical Commission (Postgraduate Medical Education Board). Guidelines for competency based postgraduate training programme for DM in Hepatology. New Delhi: NMC; 2019. nmc.org.in (PDF)
2. National Board of Examinations in Medical Sciences. NEET-SS 2025 Information Bulletin — feeder qualifications for super-speciality courses (Hepatology; Medical Gastroenterology; Paediatric Hepatology). New Delhi: NBEMS; 2025. natboard.edu.in
3. National Board of Examinations in Medical Sciences. DrNB Super Specialty Courses. natboard.edu.in/dnbsuper (accessed 14 October 2026).
4. Bini EJ, Weinshel EH, Generoso R, et al. Impact of gastroenterology consultation on the outcomes of patients admitted to the hospital with decompensated cirrhosis. Hepatology. 2001;34(6):1089–1095. PMID 11731996. doi:10.1053/jhep.2001.29204
5. Mellinger JL, Moser S, Welsh DE, et al. Access to subspecialty care and survival among patients with liver disease. Am J Gastroenterol. 2016;111(6):838–844. PMID 27021199. doi:10.1038/ajg.2016.96
6. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797–1835. PMID 36727674. doi:10.1097/HEP.0000000000000323
7. Mofrad P, Contos MJ, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 2003;37(6):1286–1292. PMID 12774006. doi:10.1053/jhep.2003.50229